Concepedia

Publication | Closed Access

Role of serum soluble Fas/soluble Fas ligand and TNF‐α on response to interferon‐α therapy in chronic hepatitis C

DOI

28

Citations

0

References

2000

Year

Mitsuo Toyoda, Satoru Kakizaki, Norio Horiguchi, Ken Sato, Hisashi Takayama, Hitoshi Takagi, Takeaki Nagamine, Masatomo Mori
Liver International

Abstract

Serum sFas/sFas ligand and TNF-alpha play a possible role in pathogenesis of CH-C and also in IFN therapy. Serum sFas levels before IFN therapy may be one of the host-related factors used for evaluating the response of CH-C patients to IFN therapy.